Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors
- Conditions
- Cancer SurvivorBreast Cancer
- Interventions
- Other: educational interventionProcedure: standard follow-up careOther: counseling interventionProcedure: quality-of-life assessmentOther: questionnaire administration
- Registration Number
- NCT01824745
- Lead Sponsor
- City of Hope Medical Center
- Brief Summary
This randomized pilot clinical trial studies survivorship care planning in improving the quality of life in breast cancer survivors. Survivorship care planning may reduce stress and improve the well-being and quality of life of cancer survivors.
- Detailed Description
PRIMARY OBJECTIVES:
I. Test the effectiveness of the navigation intervention and survivorship care plan (SCP)-breast cancer survivors (BCS) template booklet on accessing and adhering to SCP-BCS guidelines compared to the control group receiving usual care and the SCP-BCS template booklet.
SECONDARY OBJECTIVES:
I. Develop a clinically and psychosocially responsive SCP-breast cancer survivors (SCP-BCS) template in English and English-Spanish adopted from American Society of Clinical Oncology (ASCO)-SCP.
II. Assess the acceptability, utility and format preference (electronic vs paper) of the SCP-BCS template.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
ARM II: Participants receive SCP-BCS template booklet and receive standard follow-up care.
After completion so study treatment, participants are followed up at 6 and 12 months.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 100
- In early survivorship phase, defined as being post-surgery to ending of active treatment to 18 months post active treatment for stage 0-3 breast cancer (BCA)
- Reside in Southern California
- BCS treated at Kaiser, an health maintenance organization (HMO) provider, will be excluded since their SCP implementation project is underway
- BCS will not be excluded based on cancer treatments received or a history of diagnosis of mild depression, anxiety, and hypertension and diabetes
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm I (SCP-BCS template booklet and counseling) quality-of-life assessment Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions. Arm II (SCP-BCS template booklet) educational intervention Participants receive SCP-BCS template booklet and receive standard follow-up care. Arm II (SCP-BCS template booklet) standard follow-up care Participants receive SCP-BCS template booklet and receive standard follow-up care. Arm I (SCP-BCS template booklet and counseling) counseling intervention Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions. Arm II (SCP-BCS template booklet) quality-of-life assessment Participants receive SCP-BCS template booklet and receive standard follow-up care. Arm II (SCP-BCS template booklet) questionnaire administration Participants receive SCP-BCS template booklet and receive standard follow-up care. Arm I (SCP-BCS template booklet and counseling) educational intervention Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions. Arm I (SCP-BCS template booklet and counseling) questionnaire administration Participants receive SCP-BCS template booklet and receive counseling sessions with a patient navigator for 40 minutes twice weekly for 4 sessions.
- Primary Outcome Measures
Name Time Method Proportion of BCS accessing a SCP from their oncology provider At 6 months Fisher's exact test will be used to test the null hypothesis (at least 40% of trial participants will have access to SCP).
- Secondary Outcome Measures
Name Time Method Proportion of BCS accessing a SCP from their oncology provider At 12 months Fisher's exact test will be used to test the null hypothesis (at least 60% of trial participants will have access to SCP).
Adherence to SCP guidelines At 12 months Fisher's exact test will be used to test the null hypothesis (at least 25% of participants reporting adherence to SCP guidelines).
Trial Locations
- Locations (2)
City of Hope Antelope Valley
🇺🇸Lancaster, California, United States
City of Hope Medical Center
🇺🇸Duarte, California, United States